Skip to main content
. 2014 Aug 21;146(5):1256–1262. doi: 10.1378/chest.14-0492

TABLE 3 ] .

Sample Size Estimates for Selected Cohorts in a Two-Year Study

Sample Size Estimate (90% Power)
Cohort/End Point HR = 0.50 HR = 0.60 HR = 0.70 HR = 0.80
GAP stage 1
 Death 4,548 7,454 13,938 33,024
 Death or hospitalization 1,302 2,140 4,014 9,532
GAP stage 2
 Death 1,820 2,988 5,596 13,280
 Death or hospitalization 456 758 1,430 3,420
GAP stage 3
 Death 456 758 1,430 3,420
 Death or hospitalization 230 386 738 1,784
GAP stages 1 and 2
 Death 2,602 4,268 7,986 18,936
 Death or hospitalization 676 1,116 2,098 5,000
GAP stages 2 and 3
 Death 730 1,204 2,264 5,390
 Death or hospitalization 306 510 968 2,328
GAP stages 1, 2, and 3
 Death 1,012 1,666 3,128 7,436
 Death or hospitalization 410 680 1,286 3,076

To achieve 90% power with a two-sided type I error of 0.05, an HR of 0.50 would require 87 events; an HR of 0.60, 161 events; an HR of 0.70, 330 events; and an HR of 0.80, 844 events. Samples sizes reported are the total sample sizes required for a two-arm study using a 1:1 allocation ratio, assuming uniform enrollment over 1 y followed by a minimum of 1-y follow-up for the last patient enrolled. One-year death rates for the control group are assumed to be 2%, 5%, and 20% for GAP stages 1, 2, and 3, respectively. One-year death or hospitalization rates for the control group are assumed to be 7%, 20%, and 40% for GAP stages 1, 2, and 3, respectively. HR = hazard ratio. See Table 1 legend for expansion of other abbreviation.